Quotes are at least 15-min delayed:2026/02/12 09:19 EST
Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
4.57/6.58
|
|
Enterprise Value
39.51B
|
| Balance Sheet |
|
Book Value Per Share
23.83
|
| Cash Flow |
|
Cash Flow Yield
0.04
|
| Income Statement |
|
Total Revenue
6.95B
|
|
Operating Revenue Per Share
24.73
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
|
Business Description
|
|||
| Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest countryconcentrations. |
